Adjuvant carboplatin for high risk triple negative breast cancer Post date 23 December 2025 ← Scotland’s resident doctors vote to strike for first time → Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer